Approximately 1% are parathyroid carcinomas, associated with inactivation of the CDC73/HRPT2 double allele, RET mutations, and in some cases HPT-JT or MEN1 syndrome (4). This evidence concerns the gene CDC73 and multiple endocrine neoplasia type 1.